683 Capital Management »

Willow Lane Acquisition Crp shares owned by 683 Capital Management

Quarter-by-quarter ownership of Willow Lane Acquisition Crp shares owned by 683 Capital Management from 13F filings

Historical chart of 683 Capital Management investment in Willow Lane Acquisition Crp

Tip: Access up to 7 years of quarterly data

All positions including Willow Lane Acquisition Crp held by 683 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Willow Lane Acquisition Crp by 683 Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.3M 125k 10.10

More positions owned by 683 Capital Management

Palantir Technologies Cl A Put Option (PLTR)
Eli Lilly & Co. (LLY)
NVIDIA Corporation Put Option (NVDA)
Capital One Financial (COF)
Alnylam Pharmaceuticals (ALNY)
Carvana Cl A (CVNA)
Madrigal Pharmaceuticals Put Option (MDGL)
Tesla Motors Put Option (TSLA)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Protagonist Therapeutics (PTGX)
Praxis Precision Medicines I Com New Put Option (PRAX)
Wave Life Sciences SHS (WVE)
Becton, Dickinson and (BDX)
Kaspi Kz Jsc Sponsored Ads (KSPI)
Anaptysbio Inc Common (ANAB)

View all positions for 683 Capital Management

Top funds holding Willow Lane Acquisition Crp

Magnetar Financial
Tenor Capital Management
LMR Partners
Saba Capital Management
Hudson Bay Capital Management
Periscope Capital
Shaolin Capital Management
Moore Capital Management
Brooklyn Capital Management
Glazer Capital
Polar Securities
Rivernorth Capital Management
Sona Asset Management
Alberta Investment Management Corporation
Toronto-Dominion Bank

View all funds holding Willow Lane Acquisition Crp